Skip to main content

Animations

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

From
To
  • Default content image

    Enrollment Now Open for The Michael J. Fox Foundation Phase IIa Clinical Trial Investigating Nilotinib in Parkinson's Disease

    Enrollment will open on an ongoing basis at a maximum of 25 clinical sites across the United States Visit foxtrialfinder.org for a list of currently recruiting sites and eligibility criteria Patients…
    Learn more Save for later

  • Default content image

    Michael J. Fox Foundation and 23andMe Announce Collaboration to Capture Parkinson's Experience at Scale and Amplify Patient Voice in Research and Care

    Fox Insight online digital platform facilitates partnership between patients and researchers to accelerate improved Parkinson's treatments and care Collaboration with 23andMe marries genetic and…
    Learn more Save for later

  • Default content image

    Michael J. Fox Foundation and Tau Consortium Announce Partnership to Develop New Imaging Tools for Devastating Neurodegenerative Diseases

    NEW YORK (October 24, 2017) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium today announce a funding partnership to accelerate development of novel positron…
    Learn more Save for later

  • Default content image

    Michael J. Fox Foundation Announces Award to Drive Phase IIa Clinical Trial Investigating Potential Safety and Benefit of Nilotinib in Parkinson's Disease

    Trial aims to establish safety of long-term nilotinib use in people with Parkinson's disease; recruitment to begin in September 2017 Endpoints to include symptomatic response and biological measures…
    Learn more Save for later

  • Default content image

    Michael J. Fox Foundation and CASIS Announce Partnership to Grow Key Parkinson's Protein on International Space Station

    LRRK2 protein part of SpaceX cargo resupply mission scheduled for August 10 Microgravity conditions allow for larger and better formed protein crystals Better crystals may provide a higher…
    Learn more Save for later

  • Default content image

    The Michael J. Fox Foundation Launches Clinician Input Study in Parkinson's Disease to Evaluate Mobile Technology in Clinical Care

    NEW YORK (June 12, 2017) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) today launched the Clinician Input Study in Parkinson's Disease (CIS-PD), a new initiative to gather and…
    Learn more Save for later

  • Default content image

    The Michael J. Fox Foundation Announces Parkinson's Disease Trial Recruitment Innovation Program

    NEW YORK (May 2, 2017) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded three clinical trial centers $125,000 each for the Parkinson's Disease Trial Recruitment Innovation…
    Learn more Save for later

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.